These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 9618412)
1. Activation of human liver 3alpha-hydroxysteroid dehydrogenase by clofibrate derivatives. Matsuura K; Hara A; Kato M; Deyashiki Y; Miyabe Y; Ishikura S; Sugiyama T; Katagiri Y J Pharmacol Exp Ther; 1998 Jun; 285(3):1096-103. PubMed ID: 9618412 [TBL] [Abstract][Full Text] [Related]
2. Dual effects of anti-inflammatory 2-arylpropionic acid derivatives on a major isoform of human liver 3alpha-hydroxysteroid dehydrogenase. Yamamoto T; Matsuura K; Shintani S; Hara A; Miyabe Y; Sugiyama T; Katagiri Y Biol Pharm Bull; 1998 Nov; 21(11):1148-53. PubMed ID: 9853403 [TBL] [Abstract][Full Text] [Related]
3. Activation of human liver 3 alpha-hydroxysteroid dehydrogenase by sulphobromophthalein. Matsuura K; Tamada Y; Deyashiki Y; Miyabe Y; Nakanishi M; Ohya I; Hara A Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):179-84. PubMed ID: 8546681 [TBL] [Abstract][Full Text] [Related]
4. Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats. Walli AK; Seidel D Res Exp Med (Berl); 1981; 179(2):153-61. PubMed ID: 7280363 [TBL] [Abstract][Full Text] [Related]
5. Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: heterogeneity monooxygenase responses. Facino RM; Carini M Pharmacol Res Commun; 1981 Oct; 13(9):861-71. PubMed ID: 7335763 [No Abstract] [Full Text] [Related]
6. Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine. Schlegel BP; Ratnam K; Penning TM Biochemistry; 1998 Aug; 37(31):11003-11. PubMed ID: 9692994 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate. Foliot A; Touchard D; Mallet L Biochem Pharmacol; 1986 May; 35(10):1685-90. PubMed ID: 3707598 [TBL] [Abstract][Full Text] [Related]
8. Mutagenesis of 3 alpha-hydroxysteroid dehydrogenase reveals a "push-pull" mechanism for proton transfer in aldo-keto reductases. Schlegel BP; Jez JM; Penning TM Biochemistry; 1998 Mar; 37(10):3538-48. PubMed ID: 9521675 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of highly water-soluble fibrate derivatives via BGLation. Nemoto H; Kamiya M; Nakamoto A; Matsushita T; Matsumura K; Hattori H; Kawamura T; Taoka C; Abe S; Ishizawa K; Miyamoto L; Tsuchiya K Bioorg Med Chem Lett; 2012 Oct; 22(20):6425-8. PubMed ID: 22975299 [TBL] [Abstract][Full Text] [Related]
10. Involvement of two basic residues (Lys-270 and Arg-276) of human liver 3 alpha-hydroxysteroid dehydrogenase in NADP(H) binding and activation by sulphobromophthalein: site-directed mutagenesis and kinetic analysis. Matsuura K; Tamada Y; Sato K; Iwasa H; Miwa G; Deyashiki Y; Hara A Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):89-93. PubMed ID: 9078247 [TBL] [Abstract][Full Text] [Related]
11. Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic? Liu HF; Vincent-Viry M; Galteau MM; Guéguen R; Magdalou J; Nicolas A; Leroy P; Siest G Eur J Clin Pharmacol; 1991; 41(2):153-9. PubMed ID: 1743248 [TBL] [Abstract][Full Text] [Related]
12. Engineering steroid 5 beta-reductase activity into rat liver 3 alpha-hydroxysteroid dehydrogenase. Jez JM; Penning TM Biochemistry; 1998 Jul; 37(27):9695-703. PubMed ID: 9657682 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs. Weithmann KU; Granzer E Artery; 1980; 8(5):475-81. PubMed ID: 7011266 [TBL] [Abstract][Full Text] [Related]
14. [Experimental research on the action of a derivative from a p-chloropenoxyisobutyric acid series on lipid parameters]. Filip M; Hriscu A; Păduraru I; Rusu M Rev Med Chir Soc Med Nat Iasi; 1986; 90(1):156-60. PubMed ID: 3764166 [No Abstract] [Full Text] [Related]
15. Branched chain amino acid oxidation in cultured rat skeletal muscle cells. Selective inhibition by clofibric acid. Pardridge WM; Casanello-Ertl D; Duducgian-Vartavarian L J Clin Invest; 1980 Jul; 66(1):88-93. PubMed ID: 7400311 [TBL] [Abstract][Full Text] [Related]
16. Human liver class I alcohol dehydrogenase gammagamma isozyme: the sole cytosolic 3beta-hydroxysteroid dehydrogenase of iso bile acids. Marschall HU; Oppermann UC; Svensson S; Nordling E; Persson B; Höög JO; Jörnvall H Hepatology; 2000 Apr; 31(4):990-6. PubMed ID: 10733557 [TBL] [Abstract][Full Text] [Related]
17. Fibrates reduce triacylglycerol content by upregulating adipose triglyceride lipase in the liver of rats. Karahashi M; Hoshina M; Yamazaki T; Sakamoto T; Mitsumoto A; Kawashima Y; Kudo N J Pharmacol Sci; 2013; 123(4):356-70. PubMed ID: 24292381 [TBL] [Abstract][Full Text] [Related]
18. Structure-specific effects of thyroxine analogs on human liver 3 alpha-hydroxysteroid dehydrogenase. Yamamoto T; Nozaki A; Shintani S; Ishikura S; Katagiri Y; Hara A J Biochem; 2000 Jul; 128(1):121-8. PubMed ID: 10876166 [TBL] [Abstract][Full Text] [Related]
19. Effects of fibric acid derivatives on biliary lipid composition. Palmer RH Am J Med; 1987 Nov; 83(5B):37-43. PubMed ID: 3318452 [TBL] [Abstract][Full Text] [Related]
20. Kinetic alteration of a human dihydrodiol/3alpha-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine. Ohta T; Ishikura S; Shintani S; Usami N; Hara A Biochem J; 2000 Dec; 352 Pt 3(Pt 3):685-91. PubMed ID: 11104674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]